Detalhe da pesquisa
1.
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study.
Int J Mol Sci
; 24(2)2023 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675262
2.
Patient engagement in melanoma research: from bench to bedside.
Future Oncol
; 17(28): 3705-3716, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213356
3.
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis.
Front Oncol
; 13: 1163768, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37324003
4.
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves.
Cancers (Basel)
; 14(16)2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36010932
5.
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital.
JCO Clin Cancer Inform
; 6: e2100177, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35609228
6.
Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibition as Maintenance Treatment for SCLC: The Search Must Continue.
J Thorac Oncol
; 16(8): 1236-1238, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304849